Incidence and risk of hypertension with bevacizumab in non-small-cell lung cancer patients: a meta-analysis of randomized controlled trials

AIM: A study was conducted to determine the overall risk and incidence of hypertension with bevacizumab in non-small-cell lung cancer (NSCLC) patients. MATERIALS AND METHODS: Electronic databases such as the Embase, PubMed, and Cochrane Library were searched for related trials. Statistical analyses...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jian, Lu, Yingfeng, Zheng, Yunliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4547635/
https://www.ncbi.nlm.nih.gov/pubmed/26316712
http://dx.doi.org/10.2147/DDDT.S87258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4547635/
https://www.ncbi.nlm.nih.gov/pubmed/26316712
http://dx.doi.org/10.2147/DDDT.S87258

Ejemplares similares